Milestone Net Debt from 2010 to 2024

MLSS Stock

USD 0.99 0.03 2.94%

Milestone Scientific Net Debt yearly trend continues to be comparatively stable with very little volatility. Net Debt will likely drop to about -2.7 M in 2024. Net Debt is the total debt of Milestone Scientific minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

1996-06-30

Previous Quarter

-5.4 M

Current Value

-4.5 M

Quarterly Volatility

4.7 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Milestone Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Milestone Scientific's main balance sheet or income statement drivers, such as Depreciation And Amortization of 142.8 K, Interest Expense of 59.7 K or Selling General Administrative of 8.5 M, as well as many indicators such as Price To Sales Ratio of 8.51, Dividend Yield of 0.0 or PTB Ratio of 4.26. Milestone financial statements analysis is a perfect complement when working with Milestone Scientific Valuation or Volatility modules.

Check out the analysis of Milestone Scientific Correlation against competitors.

For more information on how to buy Milestone Stock please use our How to Invest in Milestone Scientific guide.

Latest Milestone Scientific's Net Debt Growth Pattern

Below is the plot of the Net Debt of Milestone Scientific over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Milestone Scientific's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Milestone Scientific's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Milestone Net Debt Regression Statistics

	Arithmetic Mean	(4,341,800)
	Coefficient Of Variation	(110.95)
	Mean Deviation	3,817,081
	Median	(2,636,956)
	Standard Deviation	4,817,173
	Sample Variance	23.2T
	Range	14.5M
	R-Value	(0.42)
	Mean Square Error	20.5T
	R-Squared	0.18
	Significance	0.12
	Slope	(454,107)
	Total Sum of Squares	324.9T

Milestone Net Debt History

	2024	-2.7 M
	2023	-2.6 M
	2022	-8.2 M
	2021	-14.2 M
	2020	-13.3 M
	2019	-1.5 M
	2018	-743.4 K

Other Fundumenentals of Milestone Scientific

Net Debt To E B I T D A

Milestone Scientific Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Total Permanent Equity	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.94	-0.9	-0.42	-0.36	0.2	0.14	0.98	-0.02	-0.08	0.42	0.09	0.54	0.32	0.7	0.66	-0.04	0.55	0.43	0.71	0.71	0.39
Total Stockholder Equity	0.94		-0.94	-0.32	-0.42	-0.04	-0.18	0.94	-0.18	-0.19	0.38	0.07	0.62	0.1	0.74	0.6	-0.02	0.52	0.3	0.78	0.77	0.43
Net Debt	-0.9	-0.94		0.39	0.48	0.11	0.17	-0.91	0.22	0.29	-0.47	-0.14	-0.64	0.02	-0.68	-0.57	0.12	-0.57	-0.32	-0.78	-0.8	-0.5
Retained Earnings	-0.42	-0.32	0.39		0.21	0.12	-0.34	-0.52	0.0	0.58	-0.92	0.5	-0.6	-0.13	-0.69	-0.46	-0.54	-0.83	-0.69	-0.31	-0.43	-0.81
Accounts Payable	-0.36	-0.42	0.48	0.21		0.16	0.22	-0.4	0.1	-0.15	-0.45	0.1	-0.55	-0.24	-0.39	-0.33	-0.14	-0.55	-0.4	-0.3	-0.38	-0.46
Net Receivables	0.2	-0.04	0.11	0.12	0.16		0.74	0.16	0.64	0.5	-0.34	0.46	-0.51	0.75	-0.33	0.27	-0.43	-0.23	0.27	-0.33	-0.38	-0.56
Total Liab	0.14	-0.18	0.17	-0.34	0.22	0.74		0.12	0.54	0.31	0.11	0.07	-0.21	0.7	-0.13	0.17	-0.08	0.08	0.46	-0.21	-0.2	-0.12
Total Current Assets	0.98	0.94	-0.91	-0.52	-0.4	0.16	0.12		0.02	-0.21	0.52	0.05	0.59	0.3	0.74	0.74	0.02	0.65	0.56	0.66	0.68	0.47
Short Term Debt	-0.02	-0.18	0.22	0.0	0.1	0.64	0.54	0.02		0.22	-0.18	0.19	-0.24	0.56	-0.27	0.19	-0.17	-0.1	0.42	-0.34	-0.34	-0.38
Intangible Assets	-0.08	-0.19	0.29	0.58	-0.15	0.5	0.31	-0.21	0.22		-0.49	0.29	-0.32	0.6	-0.4	-0.22	-0.31	-0.41	-0.16	-0.17	-0.26	-0.51
Common Stock	0.42	0.38	-0.47	-0.92	-0.45	-0.34	0.11	0.52	-0.18	-0.49		-0.61	0.81	0.08	0.78	0.39	0.61	0.89	0.66	0.46	0.59	0.95
Treasury Stock	0.09	0.07	-0.14	0.5	0.1	0.46	0.07	0.05	0.19	0.29	-0.61		-0.45	0.0	-0.57	-0.1	-0.92	-0.34	-0.14	-0.08	-0.15	-0.57
Property Plant Equipment	0.54	0.62	-0.64	-0.6	-0.55	-0.51	-0.21	0.59	-0.24	-0.32	0.81	-0.45		0.0	0.83	0.25	0.44	0.78	0.48	0.77	0.84	0.88
Current Deferred Revenue	0.32	0.1	0.02	-0.13	-0.24	0.75	0.7	0.3	0.56	0.6	0.08	0.0	0.0		0.08	0.36	-0.01	0.12	0.56	-0.09	-0.11	-0.12
Net Tangible Assets	0.7	0.74	-0.68	-0.69	-0.39	-0.33	-0.13	0.74	-0.27	-0.4	0.78	-0.57	0.83	0.08		0.57	0.57	0.72	0.41	0.66	0.71	0.79
Total Permanent Equity	0.66	0.6	-0.57	-0.46	-0.33	0.27	0.17	0.74	0.19	-0.22	0.39	-0.1	0.25	0.36	0.57		0.17	0.49	0.55	0.06	0.11	0.25
Long Term Debt Total	-0.04	-0.02	0.12	-0.54	-0.14	-0.43	-0.08	0.02	-0.17	-0.31	0.61	-0.92	0.44	-0.01	0.57	0.17		0.5	0.26	0.06	0.13	0.62
Capital Surpluse	0.55	0.52	-0.57	-0.83	-0.55	-0.23	0.08	0.65	-0.1	-0.41	0.89	-0.34	0.78	0.12	0.72	0.49	0.5		0.77	0.46	0.58	0.89
Short Long Term Debt	0.43	0.3	-0.32	-0.69	-0.4	0.27	0.46	0.56	0.42	-0.16	0.66	-0.14	0.48	0.56	0.41	0.55	0.26	0.77		0.13	0.23	0.51
Net Invested Capital	0.71	0.78	-0.78	-0.31	-0.3	-0.33	-0.21	0.66	-0.34	-0.17	0.46	-0.08	0.77	-0.09	0.66	0.06	0.06	0.46	0.13		0.99	0.58
Net Working Capital	0.71	0.77	-0.8	-0.43	-0.38	-0.38	-0.2	0.68	-0.34	-0.26	0.59	-0.15	0.84	-0.11	0.71	0.11	0.13	0.58	0.23	0.99		0.69
Capital Stock	0.39	0.43	-0.5	-0.81	-0.46	-0.56	-0.12	0.47	-0.38	-0.51	0.95	-0.57	0.88	-0.12	0.79	0.25	0.62	0.89	0.51	0.58	0.69

Click cells to compare fundamentals

About Milestone Scientific Financial Statements

Milestone Scientific shareholders use historical fundamental indicators, such as Net Debt, to determine how well the company is positioned to perform in the future. Although Milestone Scientific investors may analyze each financial statement separately, they are all interrelated. The changes in Milestone Scientific's assets and liabilities, for example, are also reflected in the revenues and expenses on on Milestone Scientific's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	-2.6 M	-2.7 M
Net Debt To EBITDA	0.37	0.51

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Milestone Stock Analysis

When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Milestone Net Debt from 2010 to 2024

Latest Milestone Scientific's Net Debt Growth Pattern

Milestone Net Debt Regression Statistics

Milestone Net Debt History

Other Fundumenentals of Milestone Scientific

Milestone Scientific Net Debt component correlations

About Milestone Scientific Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Milestone Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY